ThermoQuest Corporation
Ticker: TMQ 355 River Oaks Parkway
Exchange: American Stock Exchange San Jose, California 95134
Industry: Manufacturing (408) 577-1053

Type of Shares:Common Shares Filing Date:1/16/96
U.S. Shares:3,000,000 Offer Date:3/19/96
Non-U.S. Shares:0 Filing Range:$13.00 - $15.00
Primary Shares:3,000,000 Offer Price:$15.00
Secondary Shares:0 Gross Spread:$0.98
Offering Amount: $42,000,000 Selling:$0.58
Expenses:$554,000 Reallowance:$0.10
Shares Out After:48,000,000
Spin out parent firm: Thermo Instrument Systems, Inc.

ManagerTierPhone
Natwest Securities LtdLead Manager (212) 602-4800
Cazenove Inc.Co-manager (212) 747-1225
Fahnestock & Co. Inc.Co-manager (212) 668-8000
Lehman Brothers IncorporatedCo-manager (212) 640-6129

Auditor: Arthur Andersen
Audited
Income
Latest
Unaudited
Income
Prior
Unaudited
Income
Balance
Sheet
12/31/95 12/31/95
Revenue:$241.91Assets:$428.04
Net Income:$21.00Liabilities:$200.30
EPS:$0.46Equity:$227.74

Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year,
unaudited figures are partial year

Business Description
The Company develops, manufactures and sells mass spectrometers, liquid chromatographs and gas chromatographs. These analytical instruments are used in the quantitative and qualitative chemical analysis of organic and inorganic compounds at ultra-trace levels of detection. The Company's products are used primarily by pharmaceutical companies for drug research, testing and quality control; by environmental laboratories for testing water, air and soil samples for compliance with environmental regulations; by chemical companies for research and quality control; by manufacturers for testing in certain industrial applications, such as the manufacture of silicon chips, and for quality control; by food and beverage companies for quality control and to test for product contamination; and in forensic applications. Industry sources estimate that the total annual worldwide market for the Company's mass spectrometry business is approximately $600 million and for its chromatography business is approximately $2.0 billion.

Use of Proceeds
Proceeds from the proposed offering used for repayment of debt, and for working capital, capital expenditures and general corporate purposes.

Last updated: 10/28/96

©1996 IPO Data Systems, Inc. - All rights reserved.